Prognostic Gene Signature
Prognostic Gene Signature - Related Videos
09:11
Evaluating the Impact of Hydraulic Fracturing on Streams using Microbial Molecular Signatures
0 Views •
Cited by 1 •
2021
Here, we present a protocol to investigate the impacts of hydraulic fracturing on nearby streams by analyzing their water and sediment microbial communities.
12:55
Using the Gene Pulser MXcell Electroporation System to Transfect Primary Cells with High Efficiency
0 Views •
Cited by 10 •
2010
This procedure shows how to use the Gene Pulser MXcell electroporation system to rapidly and easily identify the best electroporation conditions for mouse embryonic fibroblasts (MEFs) or other primary cells. Considerations for troubleshooting are also discussed in the associated video.
06:57
In Planta Gene Expression and Gene Editing in Moso Bamboo Leaves
0 Views •
Cited by 3 •
2023
In this study, a novel in planta gene expression and gene editing method mediated by Agrobacterium was developed in bamboo. This method greatly improved the efficiency of gene function validation in bamboo, which has significant implications for accelerating the process of bamboo breeding.
01:57
Gene Families
0 Views •
2020
Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate. Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
02:08
Gene Conversion
0 Views •
2020
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
FAQs
The signature combines expression values from several genes through a statistical model that produces a score or assigns a risk group. This approach evaluates the coordinated pattern rather than relying on one measurement alone. The resulting estimate links the molecular profile in a biological sample with outcomes such as recurrence, progression, or survival.
A multi-gene pattern can capture biological processes associated with tumor behavior or disease response more broadly than an isolated gene measurement. Because the genes may reflect related pathways, their combined expression can represent clinically relevant variation in the disease. This makes the resulting score useful for separating patients into different estimated-risk groups.
Gene-expression information adds a biological dimension to established clinical assessment rather than necessarily replacing it. Conventional factors and the signature can be considered together when estimating a patient’s likely course. In medicine, this combined perspective may support more informed risk stratification, follow-up planning, or treatment discussions than either type of information considered alone.
Validation in an independent patient cohort tests whether the signature retains its prognostic value beyond the data used to develop the statistical model. Consistent performance supports greater confidence that the pattern is not limited to the original patient group. This evidence is especially important before the signature is considered for routine clinical use.
First, gene-expression measurements are obtained from a biological sample. The predefined statistical model then combines those measurements into a score or risk category, which can be evaluated against outcomes such as recurrence, progression, or survival. The result is interpreted alongside conventional clinical information, with validation evidence guiding how much weight it should receive.
Its main uses are estimating likely disease outcomes, stratifying patients by risk, and supporting decisions about monitoring or treatment. Researchers may also examine whether the signature remains informative across independent cohorts. In medicine, these applications help connect molecular features of a disease with clinically meaningful endpoints, while acknowledging that rigorous validation is needed before routine adoption.
Depending on the disease and supporting patient data, a prognostic gene signature may estimate the likelihood of recurrence, progression, or survival. These endpoints translate gene-expression patterns into clinically relevant information for risk assessment. The signature does not provide an outcome in isolation; its interpretation depends on the statistical model, validation results, and clinical context.